Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study

June 6, 2024

https://www.globenewswire.com/news-release/2024/06/06/2894725/0/en/Spectral-AI-Reaches-50-Enrollment-at-Burn-Centers-for-U-S-Pivotal-Burn-Study.html

DALLAS, June 06, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 50% clinical trial site enrollment at burn centers for its 2024 pivotal study designed to validate the algorithm used by its DeepView™ System for burn indication. This pivotal study, which is targeting enrollment of 240 patients, including both adult and pediatric subjects at multiple burn centers and emergency departments across the U.S., is expected to be the final clinical trial before seeking FDA approval in 2025.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.